Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 6 matching records
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND…Department of Health and Human Services$68.1K obligationsEnds Jul 31, 2027
CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXPDepartment of Health and Human Services$237.3K obligationsEnds Mar 7, 2025
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLEDepartment of Health and Human Services$539.6K obligationsEnds Dec 31, 2027
BAAFDA-24-00123, REFERENCE FY24C3DP2: SYSTEMATIC REVIEW OF NEURODEVELOPMENTAL OUTCOME IN VULNERABLE PEDIATRIC PATIENT POPULATIONSDepartment of Health and Human Services$48.4K obligationsEnds Mar 7, 2025
THE OBJECTIVES OF THE PROPOSED STUDY ARE TO EXAMINE THE EFFECTS OF POSTNATAL MANAGEMENT APPROACHES (NON-PHARMACOLOGICAL, INCLUDING ESC VERSUS OPIOID REPLACEMENT PHARMACOTHERAPY)…Department of Health and Human Services$520.6K obligationsEnds Jun 27, 2025
OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIALDepartment of Health and Human Services$87.3K obligationsEnds Mar 28, 2025